by Gaganpreet Kaur | Apr 17, 2021 | Alzheimer's Disease
Alzheimer’s disease (AD), a neurodegenerative disease, is the leading cause of dementia worldwide (1). Although the pathophysiology of AD is diverse, it is mainly characterized by hyperphosphorylation of tau protein, accumulation of beta-amyloid peptide (Aβ),... 
by Sharen Singh | Apr 16, 2021 | Alzheimer's Disease, I. Issues, II. Roles, Medical Officers, Physical Therapy / Medicine and Rehabilitation, Prescribers
Alzheimer’s Disease (AD), the most common cause of dementia, is a progressive and fatal neurodegenerative disorder that primarily affects older adults. Though the definitive etiology of the disease is still to be uncovered, several characteristic features of the... 
by Sharen Singh | Apr 9, 2021 | Alzheimer's Disease, I. Issues, II. Roles, IV. Others, Medical Officers
The CRISPR-Cas9 genome-editing system is a part of the adaptive immune system in archaea and bacteria to defend against invasive nucleic acids from phages and plasmids. The guide RNA (sgRNA) of the system recognizes its target sequence in the genome, and the Cas9... 
by Gaganpreet Kaur | Mar 14, 2021 | Alzheimer's Disease
The World Health Organization defines dementia as a progressive deterioration of cognitive function at a level which is beyond expected in normal aging. Dementia can reduce quality of life, as it affects memory, thinking, learning capacity, judgement, and... 
by Gaganpreet Kaur | Mar 6, 2021 | Alzheimer's Disease
In 2015, with 47 million people suffering from Alzheimer’s disease (AD) and dementia, the World Health Organization and Alzheimer’s Disease International recognized AD as a global health priority (1). The prevalence of AD and dementia patients is projected to increase... 
by Smriti Haria | Feb 19, 2021 | Alzheimer's Disease, Medical Officers, Prescribers
As of 2014, 1.6% of the American population, 5 million people, were afflicted by Alzheimer’s Disease (AD) and other related dementias. This number is only expected to grow with a prediction that by 2060, AD and other dementias will affect 3.3% of Americans [1]. Like... 
Recent Comments